Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group: Twenty patients with schizophrenia were treated with the common drug and cannabidiol drop. Patients received their present treatment (atypical antipsychotic risperi
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders (DSM–5) criteria Hospitalized in 22 Bahman Hospital in Qazvin Candidate for treatment only with rispidone as an antipsychotic Patient and legal guardian willingness to enter the study Positive and Negative Syndrome Scale (PANSS) score over 60 When entering the study Absence of cognitive disorders Lack of drug resistance
Exclusion criteria
Exclusion criteria: Breastfeeding and pregnancy or desire to conceive within 3 months after completion of the plan. Consumption of stimulants and hallucinogens and cannabis Patients with schizophrenia without positive symptoms candidate for Electroconvulsive Therapy (ECT)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive symptoms. Timepoint: At the beginning of the study (before the intervention) and 2, 4 and 6 weeks after the start of treatment. Method of measurement: PANSS Questionnaire Scores (Anderson Test). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahnaz Majidi
Qazvin University of Medical Sciences
Outcome results
None listed